Partnership to End Addiction - 485
New York, 10017, United States
NCT Number: NCT03750487
A small pilot randomized controlled trial (RCT) will be conducted to test the impact of an electronic screening and brief intervention (e-SBI) on reduction in substance use (measured via self-report), associated symptoms (depression and parenting stress), and improvement in home visiting retention and substance use treatment engagement. While a pilot RCT was originally planned, the study experienced significant delays and recruitment challenges due to the COVID-19 pandemic. Therefore, after review by the DSMB and study sponsor, the decision was made to eliminate the randomization and assign all participants to the intervention condition to evaluate feasibility and acceptability of the intervention.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
New York, 10017, United States
The purpose of this clinical trial is to pilot test an electronic screening and brief intervention (e-SBI) that will be adapted for use with pregnant and postpartum women in home visiting (HV) programs. The e-SBI will be tested in a small randomized trial in two home visiting sites, with 20 home visitors and 40 clients. Home visitors will be randomized to the control intervention or the e-SBI. Clients will be surveyed at baseline, and 3- and 6- month follow-up to track e-SBI impacts on reduction in substance use (measured via self-report), associated symptoms (depression and parenting stress), and improvement in home visiting retention and substance use treatment engagement.
While a pilot RCT was originally planned, the study experienced significant delays and recruitment challenges due to the COVID-19 pandemic. Therefore, after review by the DSMB and study sponsor, the decision was made to eliminate the randomization and assign all participants to the intervention condition to evaluate feasibility and acceptability of the intervention. Total enrollment was N = 14. Four participants were assigned to the control condition prior to elimination of randomization. The remaining 10 participants were assigned to the intervention condition. Primary study outcomes were feasibility and acceptability.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Computer-delivered screening and brief motivational intervention targeting alcohol and drug use + goal-setting and content reinforcement
Computer-delivered screening and brief motivational intervention targeting healthy eating and exercise
Time frame: Upon completion of e-SBI session 1, approximately 2-4 weeks after enrollment
e-SBI session 1 completion rate (% of participants who completed e-SBI session 1)
Time frame: Upon completion of e-SBI session 1, approximately 2-4 weeks after enrollment
8-item user satisfaction survey based on the Technology Acceptance Model completed after each e-SBI session.
The scale was developed by Ondersma in prior studies of the e-SBI, it does not have a formal title. The scale measures satisfaction with the e-SBI session.
The following items are included in the scale:
Time frame: Upon completion of e-SBI session 2 (approximately 4-6 weeks after enrollment)
e-SBI session 2 completion rate (% of participants who completed e-SBI session 2)
Time frame: Upon completion of e-SBI session 2, approximately 4-6 weeks after enrollment
8-item user satisfaction survey based on the Technology Acceptance Model completed after each e-SBI session.
The scale was developed by Ondersma in prior studies of the e-SBI, it does not have a formal title. The scale measures satisfaction with the e-SBI session.
The following items are included in the scale:
The National Center on Addiction and Substance Abuse at Columbia University
Other
Home Visitation Enhancing Linkages Project (HELP 2.0)
Acronym: HELP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04873401
COVID-19, Chemically-Induced Disorders
New York, United States
View Trial DetailsNCT05378399
Adherence, Medication, Adherence, Treatment
Boston, Massachusetts, United States
View Trial DetailsNCT05286879
Behavior, Chemically-Induced Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT06008990
Buprenorphine Dependence, Chemically-Induced Disorders
Indianapolis, Indiana, United States
View Trial Details